| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $33.4M | +20.4% |
| Cost of Revenue | $14.8M | +2.3% |
| Gross Profit | $18.5M | +40.3% |
| R&D Expense | $24.7M | +5.7% |
| SG&A Expense | $10.2M | -8.3% |
| Operating Income | -$16.4M | +23.1% |
| Pre-tax Income | -$16.4M | +22.5% |
| Income Tax | -$45K | -113.4% |
| Net Income | -$16.4M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.0M | -16.4% |
| Accounts Receivable | $4.5M | +23.3% |
| Inventory | $4.7M | +7.2% |
| Current Assets | $54.7M | -13.8% |
| Total Assets | $76.4M | -12.8% |
| Current Liabilities | $8.9M | +18.7% |
| Total Liabilities | $12.0M | -0.4% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.8M | +9.3% |
| Capital Expenditures | $774K | +281.3% |
| Investing Cash Flow | $4.2M | +27.6% |
| Financing Cash Flow | $2.4M | -49.5% |
| Free Cash Flow | -$14.6M | +5.5% |
| +23.9% |
| EPS (Basic) | -$0.67 | +26.4% |
| EPS (Diluted) | -$0.67 | +26.4% |
| Stockholders' Equity |
| $64.5M |
| -14.7% |